How much BAC water for retatrutide?

Common community protocols use 1 mL per 10 mg of vial mass (yielding 10 mg/mL) or 2 mL per 10 mg (yielding 5 mg/mL). The volume you add is what determines the final concentration.

How many units is a 2 mg retatrutide dose?

At 10 mg/mL, 2 mg is 0.2 mL or 20 units on a U-100 insulin syringe. At 5 mg/mL, 2 mg is 0.4 mL or 40 units. Always check the concentration on your vial first.

How long does reconstituted retatrutide last in the fridge?

Community practice and analogous compounded GLP-1 BUDs suggest 28 to 30 days refrigerated. There is no FDA-published stability data for retatrutide because it is not an approved drug.

Can retatrutide be stored at room temperature?

Short excursions of a few hours during travel are tolerable. Sustained room-temperature storage accelerates peptide degradation and increases contamination risk. Refrigerate as soon as possible.

What if I forgot to refrigerate my reconstituted retatrutide overnight?

A single 12-hour excursion is unlikely to destroy the peptide. Repeated or longer excursions, especially in warm weather, mean the vial should be discarded. Use your judgment, conservatively.

How do I store retatrutide powder long term before reconstitution?

Sealed lyophilized vials are most stable in a freezer, second most stable refrigerated. Avoid temperature cycling. Reconstitute only as much as you will use in 28 days.

Do I shake the vial after adding BAC water?

No. Swirl or roll the vial gently. Vigorous shaking foams the peptide and can damage its structure. The powder dissolves within a minute of gentle swirling.

Is retatrutide legal in the UK?

Retatrutide is not approved by the MHRA. UK regulations classify peptides sold for research without prescription as outside the medicines framework. Importing or self-administering carries the same regulatory and safety concerns as in the US.

How do I know my vial actually contains retatrutide?

Short of independent mass spectrometry testing, you do not. A vendor certificate of analysis is paid for by the vendor and covers a single lot, not the vial in your hand.

What were the doses used in the retatrutide clinical trials?

The phase 2 obesity trial tested 1, 4, 8, and 12 mg weekly with a titration schedule. The phase 2 diabetes trial used a similar dose range. Doses outside this range have no published safety or efficacy data.

Retatrutide Reconstitution

Summary: Retatrutide is a lyophilized powder that must be dissolved in bacteriostatic water before use, but it is not FDA approved as of 2026 and any vial bought as research-grade sits outside the regulatory and quality framework that protects patients.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Before any math: retatrutide is not an FDA-approved medication as of 2026. Eli Lilly's phase 3 program is ongoing and approval, if it happens, is expected no earlier than 2027. Every retatrutide vial currently in private hands was sold as "research chemical" or "for laboratory use only" by a peptide vendor outside the pharmaceutical regulatory framework. There is no FDA-verified potency, no FDA-verified sterility, and no clinical oversight. This page exists for harm reduction. It does not endorse the practice.

If you are determined to wait for a properly studied, properly manufactured product, that is the recommendation a physician would give you, and it is the one we agree with.

The basic math

Reconstitution is one formula:

final concentration (mg/mL) = vial mg / mL of BAC water added

You have a lyophilized (freeze-dried) powder in a sealed vial. You inject bacteriostatic water (BAC water, which is sterile water containing 0.9% benzyl alcohol as a preservative) through the rubber stopper. The powder dissolves. The total liquid volume equals the volume of water you added, because the dry peptide contributes negligible volume at these masses.

A 10 mg vial reconstituted with 1 mL of BAC water yields 10 mg/mL. The same 10 mg vial reconstituted with 2 mL yields 5 mg/mL. The vendor did not change the dose; you did.

Common reconstitution protocols seen in the peptide community

These are the volumes most frequently used in online community guides. Listing them is not an endorsement.

Vial mass	BAC water added	Final concentration	mg per 10 units (U-100)
5 mg	1 mL	5 mg/mL	0.5 mg
5 mg	2 mL	2.5 mg/mL	0.25 mg
10 mg	1 mL	10 mg/mL	1.0 mg
10 mg	2 mL	5 mg/mL	0.5 mg
15 mg	1.5 mL	10 mg/mL	1.0 mg
20 mg	2 mL	10 mg/mL	1.0 mg
20 mg	4 mL	5 mg/mL	0.5 mg
30 mg	3 mL	10 mg/mL	1.0 mg

The two most common protocols are 10 mg vial + 1 mL = 10 mg/mL and 10 mg vial + 2 mL = 5 mg/mL. The first concentrates the dose into a smaller injection volume. The second halves the concentration so each unit on the syringe corresponds to a smaller milligram step, which makes microdosing easier and keeps the math comparable to brand tirzepatide pens, which run at 5 mg/mL.

Drawing the dose on an insulin syringe

A U-100 insulin syringe is calibrated so 100 units equals 1 mL. The unit number you draw to is the volume in mL multiplied by 100. The dose in mg equals that volume times the concentration.

units = (desired mg / concentration in mg/mL) x 100

Worked example at 10 mg/mL. You want a 2 mg dose.

mL = 2 / 10 = 0.2 mL
units = 0.2 x 100 = 20 units

Worked example at 5 mg/mL. You want the same 2 mg dose.

mL = 2 / 5 = 0.4 mL
units = 0.4 x 100 = 40 units

Same dose, different syringe reading, because the concentration changed. This is the single most common source of error. Read the concentration off the vial every time. Do not rely on memory across refills.

What dose is "right"

The published phase 2 retatrutide doses are 1, 2, 4, 8, and 12 mg per week, with a titration schedule that started at 2 mg or 4 mg and stepped up monthly ^[1]. The 8 mg and 12 mg arms produced the largest weight loss in the obesity trial. The diabetes trial used a similar titration ^[2].

There is no published clinical guidance for doses outside this range. People who start at 0.5 mg are doing so because community lore suggests it reduces GI side effects during initiation. There is no trial data confirming that 0.5 mg has any meaningful effect. People running 16 mg or 20 mg per week are extrapolating past the dose ceiling Lilly actually tested. The pharmacokinetics, the safety profile, and the side effect curve at those doses are not characterized.

Step-by-step mixing

Decide on your target concentration. Write the math down before you touch a needle.
Draw the chosen volume of BAC water into a sterile syringe. A 3 mL or 5 mL syringe with a 21-gauge or 25-gauge needle handles this well.
Insert the needle into the peptide vial at a slight angle so the stream hits the inner side wall of the vial, not the powder directly. A direct stream onto the lyophilized cake can foam the peptide and increase the risk of denaturation. Slow injection over a few seconds is better than a fast push.
Withdraw the empty syringe.
Do not shake. Roll the vial gently between your palms or swirl it on the counter for 30 to 60 seconds. The powder dissolves quickly. The solution should be clear and colorless. Cloudiness, particles, or a yellow tint suggest a contaminated or degraded vial; do not use it.
Label the vial with the date of reconstitution and the final concentration. A piece of medical tape with a permanent marker works. Without a label you will guess wrong within two refrigerator cycles.
Store immediately in the refrigerator.

Storage after reconstitution

Reconstituted retatrutide is a peptide in aqueous solution and degrades faster than the lyophilized powder. There is no FDA-published beyond-use date for retatrutide because there is no FDA-approved retatrutide product. Community consensus, drawn loosely from analogous peptides like semaglutide and tirzepatide, places the practical window at:

Refrigerated (36 to 46 degrees Fahrenheit, 2 to 8 Celsius): 28 to 30 days. This matches the BUD that compounding pharmacies typically assign to reconstituted GLP-1 multi-dose vials under USP 797 guidance ^[4]. Some users push it to 56 days; the longer you keep it, the more potency loss and contamination risk you accept.
Frozen (below 0 Fahrenheit): up to several months for the lyophilized powder before reconstitution. Once reconstituted, do not freeze. The freeze-thaw cycle damages the peptide structure.
Room temperature: avoid. A few hours during travel between the pharmacy and your fridge is tolerable. Days at room temperature are not. The benzyl alcohol in BAC water suppresses bacterial growth but does not prevent peptide hydrolysis.

If you forgot to refrigerate a reconstituted vial overnight, the practical decision is yours. A single 12-hour room-temperature excursion will not destroy the peptide outright, but every excursion shortens shelf life and adds risk. A vial left out for several days in warm weather should be discarded.

Storing the lyophilized powder long term

Unopened lyophilized retatrutide is more stable than the reconstituted solution. Vendors typically ship with cold packs and recommend refrigeration. Stored at refrigerator temperature, sealed, in the original vial, the powder is generally stable for the labeled shelf life (often 12 to 24 months from manufacture; check the vendor's certificate of analysis if one was provided). Stored in a freezer, the powder is more stable still, and many community guides recommend long-term freezer storage for unopened vials.

The legal and safety reality

The FDA has explicitly warned the public about unapproved GLP-1 products sold online and stated that compounded GLP-1s outside approved formulations carry risks that include "dosing errors, infections, and serious adverse events" ^[5]. Retatrutide is not on the FDA shortage list because retatrutide is not an approved drug at all. There is no legal compounding pathway for it in the United States. Vendors selling retatrutide as a "research chemical" are operating in a legal gray zone that depends on the buyer not injecting it.

What this means practically:

No quality assurance. The mass on the vial label is what the vendor says is in the vial. Independent assays have found research-peptide potency variability of 10 percent to over 50 percent in some cases.
No sterility guarantee. Lyophilized peptides are not sterile-filtered to pharmaceutical standards by most peptide vendors. BAC water suppresses bacterial growth but does not sterilize a contaminated vial.
No clinical supervision. No prescriber is checking your kidney function, watching for pancreatitis, monitoring your gallbladder, or catching the rare cases where a GLP-1 unmasks a thyroid problem. The phase 2 trial reported GI side effects in over 80 percent of high-dose participants and adjudicated several serious adverse events ^[1]; clinical trials catch these problems because trained physicians are looking.
No legal recourse. If a research-grade vial contains the wrong compound, the wrong dose, or a contaminant, the legal framework that protects consumers of FDA-approved drugs does not apply.

The honest harm-reduction answer is to wait for FDA approval, then use the approved product under medical supervision. Approval is expected within the next year or two given the strength of the phase 2 data and the size of the phase 3 program already underway. If that timeline is unacceptable and you have decided to use research-grade material anyway, you are taking on every link in the quality chain that a pharmaceutical company normally handles, and the consequences of any failure in that chain are yours alone.

Reconstitution calculator logic

If you want to verify a calculator's math by hand, the three formulas to memorize are:

concentration (mg/mL) = vial mass / BAC water mL
volume per dose (mL) = desired mg / concentration
units on U-100 syringe = volume per dose x 100

A calculator that asks for vial mass, BAC water volume, and desired weekly dose, then returns the syringe unit number, is doing exactly those three operations. There is no hidden complexity. If the number it gives you does not match a hand-check, do not use it.

Brand pen comparison (none, yet)

Unlike tirzepatide (Mounjaro, Zepbound) or semaglutide (Ozempic, Wegovy), there is no Eli Lilly retatrutide pen on any market. No pen, no auto-injector, no prefilled syringe. Every retatrutide injection in private use right now goes through a manually drawn insulin syringe from a manually reconstituted vial. When approval arrives, expect Lilly to ship retatrutide in single-use auto-injectors similar to the Zepbound pen, with the reconstitution question disappearing entirely for legal supply.

Frequently asked questions

How much BAC water for retatrutide?: Common community protocols use 1 mL per 10 mg of vial mass (yielding 10 mg/mL) or 2 mL per 10 mg (yielding 5 mg/mL). The volume you add is what determines the final concentration.
How many units is a 2 mg retatrutide dose?: At 10 mg/mL, 2 mg is 0.2 mL or 20 units on a U-100 insulin syringe. At 5 mg/mL, 2 mg is 0.4 mL or 40 units. Always check the concentration on your vial first.
How long does reconstituted retatrutide last in the fridge?: Community practice and analogous compounded GLP-1 BUDs suggest 28 to 30 days refrigerated. There is no FDA-published stability data for retatrutide because it is not an approved drug.
Can retatrutide be stored at room temperature?: Short excursions of a few hours during travel are tolerable. Sustained room-temperature storage accelerates peptide degradation and increases contamination risk. Refrigerate as soon as possible.
What if I forgot to refrigerate my reconstituted retatrutide overnight?: A single 12-hour excursion is unlikely to destroy the peptide. Repeated or longer excursions, especially in warm weather, mean the vial should be discarded. Use your judgment, conservatively.
How do I store retatrutide powder long term before reconstitution?: Sealed lyophilized vials are most stable in a freezer, second most stable refrigerated. Avoid temperature cycling. Reconstitute only as much as you will use in 28 days.
Do I shake the vial after adding BAC water?: No. Swirl or roll the vial gently. Vigorous shaking foams the peptide and can damage its structure. The powder dissolves within a minute of gentle swirling.
Is retatrutide legal in the UK?: Retatrutide is not approved by the MHRA. UK regulations classify peptides sold for research without prescription as outside the medicines framework. Importing or self-administering carries the same regulatory and safety concerns as in the US.
How do I know my vial actually contains retatrutide?: Short of independent mass spectrometry testing, you do not. A vendor certificate of analysis is paid for by the vendor and covers a single lot, not the vial in your hand.
What were the doses used in the retatrutide clinical trials?: The phase 2 obesity trial tested 1, 4, 8, and 12 mg weekly with a titration schedule. The phase 2 diabetes trial used a similar dose range. Doses outside this range have no published safety or efficacy data.

What this article does not do

This page does not tell you it is safe to use research-grade retatrutide. It is not. It does not recommend a specific dose for you. There is no clinically supervised dose for material that was not manufactured under pharmaceutical quality controls. It does not endorse any vendor, calculator, or community protocol. It documents the math and storage practices that exist in the peptide community so people who have already decided to proceed can at least avoid the most obvious arithmetic and handling errors. The lower-risk option remains waiting for Eli Lilly's regulatory approval and using a real prescription under real supervision.